Mortality in COVID-19 hospitalizations with underlying hematologic malignancies in the United States
- PMID: 37177861
- DOI: 10.1002/hon.3173
Mortality in COVID-19 hospitalizations with underlying hematologic malignancies in the United States
References
REFERENCES
-
- Langerbeins P, Hallek M. COVID-19 in patients with hematologic malignancy. Blood. 2022;140(3):236-252. https://doi.org/10.1182/blood.2021012251
-
- Pagano L, Salmanton-García J, Marchesi F, et al. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA). J Hematol Oncol. 2021;14(1):168. https://doi.org/10.1186/s13045-021-01177-0
-
- Vijenthira A, Gong IY, Fox TA, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136(25):2881-2892. https://doi.org/10.1182/blood.2020008824
-
- Chiaretti S, Bonifacio M, Agrippino R, et al. ACUTE lymphoblastic leukemia (ALL) and COVID-19 infection. A campus ALL report. Blood. 2021;138(suppl 1):216. https://doi.org/10.1182/blood-2021-150958
-
- Ribera JM, Morgades M, Coll R, et al. Frequency, clinical characteristics and outcome of adults with acute lymphoblastic leukemia and COVID 19 infection in the first vs. second pandemic wave in Spain. Clin Lymphoma Myeloma Leuk. 2021;21(10):e801-e809. https://doi.org/10.1016/j.clml.2021.06.024
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
